[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338202-105":59,"doc-detail-338202-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","decoding-functional-impact-of-epigenetic-regulator-mutations-on-ligandreceptor-interaction-perturbations-for-evaluation-of-cancer-immunotherapy","Decoding functional impact of epigenetic regulator mutations on ligand–receptor interaction perturbations for evaluation of cancer immunotherapy","","Cellular crosstalk mediated by ligand–receptor interactions shapes the tumour ecosystem by driving heterogeneous tumour microenvironments that influence immune response and the clinical benefits of immunotherapy. Epigenetic mechanisms control expression of immune-related genes and modulate anti-tumour immunity. Yet the functional effects of disrupted epigenetic regulators on ligand–receptor interactions in the tumour microenvironment remain insufficiently understood.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/decoding-functional-impact-of-epigenetic-regulator-mutations-on-ligandreceptor-interaction-perturbations-for-evaluation-of-cancer-immunotherapy/338202/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/decoding-functional-impact-of-epigenetic-regulator-mutations-on-ligandreceptor-interaction-perturbations-for-evaluation-of-cancer-immunotherapy/338202.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main problem addressed in the study?","Question",{"text":113,"@type":114},"The study targets the limited understanding of how disrupted epigenetic regulators affect ligand–receptor interaction perturbations in the tumour microenvironment and thereby influence cancer immunotherapy evaluation.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What approach does the paper propose?",{"text":118,"@type":114},"It proposes MERIN, a molecular network-based approach that integrates multiomics data to infer potential consequences of epigenetic regulator mutations on ligand–receptor interaction perturbations.",{"name":120,"@type":111,"acceptedAnswer":121},"What key findings are reported from the analysis?",{"text":122,"@type":114},"Across 33 cancers, dysregulated ligand–receptor genes were enriched in cancer and immune-related functions. The paper highlights PD1–PDL1 interaction-related epigenetic regulator mutations for stratifying patients, with distinct immunological characterizations and prognoses, and potential prediction of immunotherapy outcomes.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338202,1790673283,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":19,"preview_urls":146},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","DOI: 10. 1111/jcmm.70009  \nOR I G I NAL ART I C L E  \nDecoding functional impact of epigenetic regulator mutations on ligand–receptor interaction perturbations for evaluation of cancer immunotherapy  \nAiai Shi1,2,3 | Chaohuan Lin1,4 | Jie Lyu1,3,5   \n1Joint Centre of Translational Medicine, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, People's Republic of China  \n2Institute of Theoretical Physics, Chinese Academy of Sciences, Beijing, People's Republic of China  \n3Joint Centre of Translational Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China 4Postgraduate Training Base Alliance of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China 5Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou, Zhejiang, People's Republic of China  \nCorrespondence  \nJie Lyu, Joint Centre of Translational Medicine, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, People's Republic of China.  \nEmail: [lvjie@ucas.ac.cn](lvjie@ucas.ac.cn)  \nFunding information  \nWenzhou Institute, University of Chinese Academy of Sciences’ startup fund, Grant/ Award Number: WIUCASQD2021006; National Natural Science Foundation of China, Grant/Award Number: 32170665  \nAbstract  \nCellular crosstalk mediated by ligand–receptor interactions largely complicates the tumour ecosystem, resulting in heterogeneous tumour microenvironments that affect immune response and clinical benefits from immunotherapy. Epigenetic mechanisms are pivotal to expression changes of immune-related genes and can modulate the anti-tumour immune response. However, the functional consequences of disrupted epigenetic regulators (ERs) on ligand–receptor interactions in the tumour microenvironment remain largely unexplored. Here, we proposed mutations of ERs in perturbed interactions (MERIN), a molecular network-based approach that incorporates multiomics data, to infer the potential consequences of ER mutations on ligand–receptor interaction perturbations. Leveraging cancer genomic profiles and molecular interaction data, we comprehensively decoded the functional consequences of ER mutations on dysregulated ligand–receptor interactions across 33 cancers. The dysregulated ligand–receptor genes were indeed enriched in cancer and immune-related function. We demonstrated the potential significance of PD1–PDL1 interaction-related ER mutations in stratifying cancer patients from multiple independent data cohorts. The ER mutation group showed distinct immunological characterizations and prognoses. Furthermore, we highlighted that the ER mutations could potentially predict clinical outcomes of immunotherapy. Our computational and clinical assessment underscore the utility of MERIN for elucidating the functional relevance of ER mutations in cancer immune response, potentially aiding patients' stratification for immunotherapy.  \nK E Y WO R D S  \ncancer, epigenetic regulator, immune, immunotherapy, ligand–receptor interaction, mutation  \n1 | INTRODUCTION  \nThe complexity of tumours is reflected by complicated and dynamic crosstalk among microenvironment cells and molecules.1 Cellular crosstalk mediated by ligand–receptor interactions in the tumour  \nmicroenvironment (TME) plays a crucial role in the processes of tumorigenesis, progression and therapy resistance.1,2 For example, the ligand–receptor interaction of PDL1–PD1 can mediate the crosstalk between tumour cells and CD8 T cells, thereby suppressing anti-tumour immunity by delivering negative signalling to CD8 T  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Author(s) . Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.  \nJ ","cbCaipUXCJ4dt0H1","https://ap.wps.com/l/cbCaipUXCJ4dt0H1","pdf",1791249,12,"English","# Abstract\n## Introduction","[{\"question\":\"What is the main problem addressed in the study?\",\"answer\":\"The study targets the limited understanding of how disrupted epigenetic regulators affect ligand–receptor interaction perturbations in the tumour microenvironment and thereby influence cancer immunotherapy evaluation.\"},{\"question\":\"What approach does the paper propose?\",\"answer\":\"It proposes MERIN, a molecular network-based approach that integrates multiomics data to infer potential consequences of epigenetic regulator mutations on ligand–receptor interaction perturbations.\"},{\"question\":\"What key findings are reported from the analysis?\",\"answer\":\"Across 33 cancers, dysregulated ligand–receptor genes were enriched in cancer and immune-related functions. The paper highlights PD1–PDL1 interaction-related epigenetic regulator mutations for stratifying patients, with distinct immunological characterizations and prognoses, and potential prediction of immunotherapy outcomes.\"}]","Decoding functional impact of epigenetic regulator mutations on ligand–receptor interaction perturbations for evaluation of cancer immunotherapy | PDF",1790022501,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e52c5e4ec7173f591854c7654f70a9d.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bfd54d26b82d63f049d91d77b6ba330e.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a09096609906cdbc8b528c7407e63021.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95fd7af4d7c260fe5ebba650f9b87538.webp",980,1287]